Edesa Biotech's total assets for Q3 2024 were $5.23M, a decrease of -19.26% from the previous quarter. EDSA total liabilities were $2.36M for the fiscal quarter, a 9.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.